Collagen XVIII mutation in Knobloch syndrome with acute lymphoblastic leukemia.
Knobloch syndrome (KNO) is caused by mutations in the collagen XVIII gene (COL18A1) and patients develop encephalocele and vitreoretinal degeneration. Here, we report an El Salvadorian family where two sisters showed features of KNO. One of the siblings also developed acute lymphoblastic leukemia. DNA sequencing of COL18A1 revealed a homozygous, 2-bp deletion (c3514-3515delCT) in exon 41, which leads to abnormal collagen XVIII and deficiency of its proteolytic cleavage product endostatin. KNO patients with mutations in COL18A1 may be at risk for endostatin-related conditions including malignancy.
Mahajan
Vinit B
VB
Department of Ophthalmology and Visual Sciences, The University of Iowa Hospitals & Clinics, Iowa City, Iowa, USA.
Olney
Ann Haskins
AH
Garrett
Penny
P
Chary
Ajit
A
Dragan
Ecaterina
E
Lerner
Gary
G
Murray
Jeffrey
J
Bassuk
Alexander G
AG
D001483:Base Sequence; D002648:Child; D002675:Child, Preschool; D043170:Collagen Type XVIII / Q000235:genetics*; D004252:DNA Mutational Analysis; D004677:Encephalocele / Q000150:complications / Q000235:genetics; D005124:Eye Abnormalities / Q000235:genetics; D005190:Family; D005260:Female; D006801:Humans; D007223:Infant; D008279:Magnetic Resonance Imaging; D008297:Male; D008969:Molecular Sequence Data; D009154:Mutation / Q000235:genetics*; D010375:Pedigree; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma / Q000150:complications* / Q000235:genetics*; D012162:Retinal Degeneration; D012163:Retinal Detachment / Q000150:complications / Q000151:congenital / Q000235:genetics
D043170:Collagen Type XVIII
Cell. 1997 Jan 24;88(2):277-85
9008168
Am J Med Genet. 1993 Apr 15;46(2):203-8
8484411
EMBO J. 2002 Apr 2;21(7):1535-44
11927538
Ann Surg Oncol. 2008 Dec;15(12):3601-8
18818971
Methods Find Exp Clin Pharmacol. 2003 Apr;25(3):215-24
12743627
Int J Cancer. 2008 Jun 15;122(12):2805-10
18360823
Am J Med Genet A. 2003 May 15;119A(1):15-9
12707952
Clin Cancer Res. 2004 Aug 15;10(16):5361-6
15328173
Hum Mutat. 2004 Jan;23(1):77-84
14695535
Ann Oncol. 2010 Jan;21(1):78-86
19622587
Scott Med J. 1975;20(1 SUPPL):45-8
1154013
J Clin Oncol. 2009 Nov 1;27(31):5175-81
19805687
Hum Mol Genet. 2000 Aug 12;9(13):2051-8
10942434
Leukemia. 2005 Aug;19(8):1312-7
15931265
Biochemistry (Mosc). 2007 Mar;72(3):235-46
17447877
Am J Med Genet B Neuropsychiatr Genet. 2009 Oct 5;150B(7):993-7
19160445
Am J Med Genet. 2000 Jan 17;90(2):146-9
10607954
Am J Med Genet A. 2007 Dec 1;143A(23):2768-74
17975799
Int J Cancer. 2006 Dec 15;119(12):2901-6
16998835
Eur J Pharmacol. 2009 Jul 1;614(1-3):1-6
19389394
Am J Med Genet. 1998 Jul 7;78(3):286-90
9677068
Lung Cancer. 2002 Jan;35(1):29-34
11750710
Cancer. 2002 Oct 15;95(8):1637-43
12365010
Am J Med Genet. 1994 Aug 15;52(2):170-3
7802003
Leuk Res. 2007 May;31(5):629-38
17011029
Hum Mol Genet. 1996 Jun;5(6):843-7
8776601
Ophthalmology. 2004 Oct;111(10):1885-8
15465551
Curr Opin Hematol. 1998 Jul;5(4):292-301
9747636
Am J Hum Genet. 2002 Dec;71(6):1320-9
12415512